Merck Sharp & Dohme Corp. v. Ajanta Pharma Limited et al
Plaintiff: Merck Sharp & Dohme Corp.
Defendant: Ajanta Pharma Limited and Ajanta Pharma USA Inc.
Case Number: 1:2020cv00815
Filed: June 17, 2020
Court: U.S. District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on August 7, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
August 7, 2020 Filing 12 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Certification)(Bilson, David) Modified on 8/7/2020 (nms).
August 7, 2020 Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Carolyn A. Blessing and Christopher J. Cassella - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Certification, #2 Certification, #3 Certification)(Bilson, David) Modified on 8/7/2020 (nms).
August 7, 2020 Pro Hac Vice Attorneys Michael J. Gaertner, Carolyn A. Blessing, Christopher J. Cassella, David B. Abramowitz for Ajanta Pharma Limited and Ajanta Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
August 7, 2020 Opinion or Order SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz, filed by Ajanta Pharma USA Inc., Ajanta Pharma Limited. Signed by Judge Richard G. Andrews on 8/7/2020. (nms)
August 7, 2020 Opinion or Order SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Carolyn A. Blessing and Christopher J. Cassella, filed by Ajanta Pharma USA Inc., Ajanta Pharma Limited. Signed by Judge Richard G. Andrews on 8/7/2020. (nms)
July 30, 2020 Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ajanta Pharma Limited. (Phillips, John)
July 30, 2020 Filing 9 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ajanta Pharma Limited for Ajanta Pharma USA Inc. filed by Ajanta Pharma USA Inc.. (Phillips, John)
July 30, 2020 Filing 8 ANSWER to #1 Complaint and Affirmative Defenses, by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Phillips, John) Modified on 7/31/2020 (nms).
July 2, 2020 Filing 7 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Ajanta Pharma USA Inc. waiver sent on 6/19/2020, answer due 8/18/2020. (Silver, Daniel)
July 2, 2020 Filing 6 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Ajanta Pharma Limited waiver sent on 6/19/2020, answer due 8/18/2020. (Silver, Daniel)
June 24, 2020 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
June 17, 2020 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (myr)
June 17, 2020 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (myr)
June 17, 2020 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 6, 2020. Date of Expiration of Patent: November 24, 2026.Thirty Month Stay Deadline: No earlier than 11/6/2022. (myr)
June 17, 2020 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
June 17, 2020 Filing 1 COMPLAINT filed against Ajanta Pharma Limited, Ajanta Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3000269.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(myr)
June 17, 2020 No Summons Issued. (myr)

Access additional case information on PACER

Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Merck Sharp & Dohme Corp. v. Ajanta Pharma Limited et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ajanta Pharma Limited
Represented By: David B. Abramowitz
Represented By: John C. Phillips, Jr.
Represented By: Michael J. Gaertner
Represented By: David A. Bilson
Represented By: Carolyn A. Blessing
Represented By: Christopher J. Cassella
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ajanta Pharma USA Inc.
Represented By: David B. Abramowitz
Represented By: John C. Phillips, Jr.
Represented By: Michael J. Gaertner
Represented By: David A. Bilson
Represented By: Carolyn A. Blessing
Represented By: Christopher J. Cassella
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Merck Sharp & Dohme Corp.
Represented By: Alexandra M. Joyce
Represented By: Daniel M. Silver
Represented By: Michael P. Kelly
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?